Clinical trial to study the effect of Rajikushthadi Lepa in pama with special reference to scabies
Not Applicable
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2024/08/071839
- Lead Sponsor
- Dr Shruti Bhaskar Bhadane
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of school going age group (6 -12 years)
Patients fulfilling the clinical diagnostic criterion for scabies
Selection of patient will be performed irrespective of sex, socio
economic status and community
Parents willing to give consent in written for the treatment
Exclusion Criteria
Patients of other age group
Pama associated with immunodeficiency disorders such as HIV
Scabies with crust or hyperkeratosis and secondary infection
Known cases of systemic disorders such as diabetes mellitus type 1
Pama associated with any secondary infection.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in signs and symptoms of pama like Kandu(itching),Tod(pain),Dah <br/ ><br>(burning sensation),Pitika(Burrows),Strav(discharge) after application of Rajikushthadi lepaTimepoint: 11 days
- Secondary Outcome Measures
Name Time Method To compare the effect of trial & control drug on following signs & symptoms of pama <br/ ><br>Kandu(itching)Toda(Pain) <br/ ><br>Pitika(Burrows) Strav(Discharge) Dah(Burning sensation)Timepoint: 18 month